NeoGenomics [NEO] vs Thermo Fisher [TMO] Detailed Stock Comparison

NeoGenomics Inc.

NASDAQ
Loading...

Thermo Fisher Scientific Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: NeoGenomics Inc. wins in 6 metrics, Thermo Fisher Scientific Inc. wins in 12 metrics, with 0 ties. Thermo Fisher Scientific Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric NeoGenomics Inc. Thermo Fisher Scientific Inc. Better
P/E Ratio (TTM) -9.42 25.84 Thermo Fisher Scientific Inc.
Price-to-Book Ratio 1.22 3.31 NeoGenomics Inc.
Debt-to-Equity Ratio 48.95 82.91 NeoGenomics Inc.
PEG Ratio 0.28 2.29 NeoGenomics Inc.
EV/EBITDA -701.07 19.02 Thermo Fisher Scientific Inc.
Profit Margin (TTM) -14.85% 15.15% Thermo Fisher Scientific Inc.
Operating Margin (TTM) -6.56% 17.89% Thermo Fisher Scientific Inc.
EBITDA Margin (TTM) N/A 17.89% N/A
Return on Equity -12.43% 13.52% Thermo Fisher Scientific Inc.
Return on Assets (TTM) -2.90% 5.00% Thermo Fisher Scientific Inc.
Free Cash Flow (TTM) $-21.78M $6.29B Thermo Fisher Scientific Inc.
Dividend Yield N/A 0.38% N/A
1-Year Return 57.71% 16.53% NeoGenomics Inc.
Price-to-Sales Ratio (TTM) 1.42 3.86 NeoGenomics Inc.
Enterprise Value $1.28B $214.76B Thermo Fisher Scientific Inc.
EV/Revenue Ratio 1.76 4.75 NeoGenomics Inc.
Gross Profit Margin (TTM) 43.83% N/A N/A
Revenue per Share (TTM) $6 $120 Thermo Fisher Scientific Inc.
Earnings per Share (Diluted) $-0.84 $18.18 Thermo Fisher Scientific Inc.
Beta (Stock Volatility) 1.71 0.97 Thermo Fisher Scientific Inc.
Short % of Float 6.89% 1.22% Thermo Fisher Scientific Inc.

NeoGenomics Inc. vs Thermo Fisher Scientific Inc. Stock Performance Analysis

Loading Price Chart...

NEO
TMO

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
NeoGenomics Inc.-0.54%1.28%34.59%34.59%-6.96%-5.70%
Thermo Fisher Scientific Inc.0.93%0.87%8.07%0.79%-17.74%-20.05%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
NeoGenomics Inc.57.71%-33.31%-74.14%39.90%751.15%1,822.41%
Thermo Fisher Scientific Inc.16.53%-12.65%-2.72%220.94%654.32%1,231.84%

Performance & Financial Health Analysis: NeoGenomics Inc. vs Thermo Fisher Scientific Inc.

MetricNEOTMO
Market Information
Market Cap i$1.03B$174.55B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i2,557,6272,356,220
90 Day Avg. Volume i1,885,3722,071,517
Last Close$11.09$473.72
52 Week Range$4.72 - $13.74$385.46 - $643.99
% from 52W High-19.29%-26.44%
All-Time High$61.57 (Feb 15, 2021)$672.34 (Dec 27, 2021)
% from All-Time High-81.99%-29.54%
Growth Metrics
Quarterly Revenue Growth0.11%0.06%
Quarterly Earnings Growth0.11%0.10%
Financial Health
Profit Margin (TTM) i-0.15%0.15%
Operating Margin (TTM) i-0.07%0.18%
Return on Equity (TTM) i-0.12%0.14%
Debt to Equity (MRQ) i48.9582.91
Cash & Liquidity
Book Value per Share (MRQ)$6.49$141.96
Cash per Share (MRQ)$1.23$8.75
Operating Cash Flow (TTM) i$5.23M$8.29B
Levered Free Cash Flow (TTM) i$17.20M$5.51B
Dividends
Last 12-Month Dividend Yield iN/A0.38%
Last 12-Month Dividend iN/A$1.76

Valuation & Enterprise Metrics Analysis: NeoGenomics Inc. vs Thermo Fisher Scientific Inc.

MetricNEO (Apr 24, 2026)TMO (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i-9.4225.84
Forward P/E i24.4917.16
PEG Ratio i0.282.29
Price to Sales (TTM) i1.423.86
Price to Book (MRQ) i1.223.31
Market Capitalization
Market Capitalization i$1.03B$174.55B
Enterprise Value i$1.28B$214.76B
Enterprise Value Metrics
Enterprise to Revenue i1.764.75
Enterprise to EBITDA i-701.0719.02
Risk & Other Metrics
Beta i1.710.97
Book Value per Share (MRQ) i$6.49$141.96

Financial Statements Comparison: NeoGenomics Inc. vs Thermo Fisher Scientific Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricNEO (2025)TMO (2025)
Revenue/Sales i727.33M44.56B
Cost of Goods Sold i413.04M26.32B
COGS % of Revenue i56.8%59.1%
Gross Profit i314.29M18.24B
Gross Margin i43.2%40.9%
Research & Development i37.08M1.40B
Operating Income (EBIT) i-88.13M8.11B
Operating Margin i-12.1%18.2%
EBITDA i-10.94M11.86B
EBITDA Margin i-1.5%26.6%
Pre-Tax Income i-110.27M7.31B
Pre-Tax Income % of Revenue i-15.2%16.4%
Income Tax i-2.24M547.00M
Income Tax % of Revenue i-0.3%1.2%
Net Income (Profit) i-108.03M6.72B
Profit Margin i-14.9%15.1%

Balance Sheet & Liquidity Metrics

MetricNEO (2025)TMO (2025)
Cash & Equivalents i159.62M9.85B
Total Current Assets i376.29M28.71B
Total Current Assets % of Revenue i51.7%64.4%
Total Current Liabilities i88.30M15.19B
Total Current Liabilities % of Revenue i12.1%34.1%
Long-Term Debt i404.68M35.85B
Long-Term Debt % of Revenue i55.6%80.5%
Total Shareholders Equity i836.56M53.54B
Retained Earnings i-433.81M59.16B
Retained Earnings % of Revenue i-59.6%132.8%
Property, Plant & Equipment i182.70M0

Cash Flow Statement Comparison

MetricNEO (2025)TMO (2025)
Operating Cash Flow i-8.44M7.82B
Operating Cash Flow % of Revenue i-1.2%17.5%
Capital Expenditures i-27.01M-1.48B
Free Cash Flow i-21.78M6.29B
FCF Margin i-3.0%14.1%
Debt Repayment i-201.25M-3.51B
Common Stock Repurchase iN/A-3.00B

Short Interest & Institutional Ownership Analysis

MetricNEOTMO
Shares Short i7.61M4.54M
Short Ratio i4.862.38
Short % of Float i6.89%1.22%
Shares Outstanding i128.99M371.62M
Float Shares i119.22M371.07M
% Held by Insiders i1.65%0.17%
% Held by Institutions i102.85%95.23%
% Held by Public i-4.50%4.60%

Dividend Analysis & Yield Comparison: NeoGenomics Inc. vs Thermo Fisher Scientific Inc.

MetricNEOTMO
Last 12-Month Dividend iN/A$1.76
Last 12-Month Dividend Yield iN/A0.38%
3-Year Avg Annual Dividend iN/A$1.60
3-Year Avg Dividend Yield iN/A0.08%
3-Year Total Dividends iN/A$4.80
Ex-Dividend DateN/AMar 13, 2026